Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Thermo Fisher Scientific Inc. (TMO) had Cash Flow from Financial Activities of $-1.73B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.12B |
|
$1.62B |
|
$6.47B |
|
$4.65B |
|
$9.18B |
|
$1.94B |
|
$-115.00M |
|
$1.83B |
|
$1.83B |
|
$1.62B |
|
$1.62B |
|
$1.62B |
|
$1.62B |
|
$1.94B |
|
-- |
|
378.00M |
|
378.00M |
|
$4.28 |
|
$4.27 |
|
| Balance Sheet Financials | |
$22.30B |
|
$10.18B |
|
$80.72B |
|
$103.02B |
|
$14.89B |
|
$31.86B |
|
$37.11B |
|
$52.00B |
|
-- |
|
$-14.51B |
|
$51.02B |
|
-- |
|
| Cash Flow Statement Financials | |
$4.36B |
|
$-4.94B |
|
|
Cash Flow from Financial Activities |
$-1.73B |
$4.04B |
|
$2.01B |
|
$-2.03B |
|
-- |
|
$-474.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|